Company registration number 08484129 (England and Wales)
AGROGEN LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
AGROGEN LIMITED
CONTENTS
Page
Balance sheet
1
Statement of changes in equity
2
Notes to the financial statements
3 - 8
AGROGEN LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
31 December 2025
30 September 2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
837,634
2,030,455
Current assets
Stocks
36,302
45,200
Debtors
5
138,267
613,248
Cash at bank and in hand
12,119
44,507
186,688
702,955
Creditors: amounts falling due within one year
6
(3,296,501)
(2,724,094)
Net current liabilities
(3,109,813)
(2,021,139)
Net (liabilities)/assets
(2,272,179)
9,316
Capital and reserves
Called up share capital
100
100
Revaluation reserve
-
0
1,259,930
Profit and loss reserves
(2,272,279)
(1,250,714)
Total equity
(2,272,179)
9,316

For the financial 15 month period ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the 15 month period in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 25 September 2026 and are signed on its behalf by:
Mr W O'Malley
Director
Company registration number 08484129 (England and Wales)
AGROGEN LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
- 2 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
£
£
£
£
Balance at 1 October 2023
100
1,376,737
(1,283,509)
93,328
Year ended 30 September 2024:
Loss and total comprehensive income
-
-
(84,012)
(84,012)
Transfers
-
-
0
116,807
116,807
Other movements
-
(116,807)
-
(116,807)
Balance at 30 September 2024
100
1,259,930
(1,250,714)
9,316
Period ended 31 December 2025:
Loss
-
-
(1,210,706)
(1,210,706)
Other comprehensive income:
Revaluation of tangible fixed assets
-
(1,259,930)
-
(1,259,930)
Total comprehensive income
-
(1,259,930)
(1,210,706)
(2,470,636)
Transfers
-
-
0
189,141
189,141
Balance at 31 December 2025
100
-
0
(2,272,279)
(2,272,179)
AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information

Agrogen Limited is a private company limited by shares incorporated in England and Wales. The registered office is 110-114 Duke Street, Liverpool, L1 5AG.

1.1
Reporting period

During the year the company changed the year end from 30th September to 31st December to coincide with group reporting. The current period figures presented in the financial statements and the related notes therefore represent a 15 month period and are not entirely comparable with the previous year.

1.2
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.3
Going concern

The financial statements have been prepared on a going concern basis.true

As at 31 December 2025, the Company had net liabilities of £2.3 million and incurred a loss for the period. The directors have considered the Company’s current financial position, including its cash flow forecasts and funding requirements for a period of at least twelve months from the date of approval of these financial statements.

Subsequent to the period end, the Company was acquired by EAG No.2 Limited and became part of the EAG Bioenergy group. The acquisition was feasible because the EAG group were able to acquire the Company’s incumbent secured debt at a significant discount following the reporting date. This enabled the EAG group to implement a comprehensive financial and operational restructuring of the Company and its underlying assets. Given the significantly discounted acquisition cost of the secured debt, acquired by way of assignment, the EAG group has committed an appropriate level of capital investment to return the Company to operational efficiency and profit.

The directors have considered the financial support available from the EAG group, together with the planned operational improvements, in their assessment of the Company’s ability to continue as a going concern. Accordingly, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future, being a period of at least twelve months from the date of approval of these financial statements, and to meet its liabilities as they fall due. The financial statements have therefore been prepared on the going concern basis.

1.4
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.5
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Leasehold land and buildings
7% straight-line
Plant and equipment
5%/10% straight-line
Fixtures and fittings
20% straight-line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.6
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

 

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.

1.7
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.

AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 5 -

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.8
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.9
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.10
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.11
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 6 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are recognised in respect of all timing differences that have originated but not reversed at the reporting date.

 

Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing differences.

 

Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity.

1.12
Leases
As lessee

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the 15 month period was:

2025
2024
Number
Number
Total
0
0
AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
- 7 -
4
Tangible fixed assets
Land and buildings
Plant and machinery etc
Total
£
£
£
Cost
At 1 October 2024
11,420
3,980,031
3,991,451
Revaluation
(11,420)
(2,366,516)
(2,377,936)
At 31 December 2025
-
0
1,613,515
1,613,515
Depreciation and impairment
At 1 October 2024
3,806
1,957,190
1,960,996
Depreciation charged in the 15 month period
-
0
122,032
122,032
Revaluation
(3,806)
(1,303,341)
(1,307,147)
At 31 December 2025
-
0
775,881
775,881
Carrying amount
At 31 December 2025
-
0
837,634
837,634
At 30 September 2024
7,614
2,022,841
2,030,455

Following the acquisition of the Company by EAG No.2 Limited on 20 January 2026, the new directors undertook a detailed review of the Company’s books and records for the period ended 31 December 2025. As part of this process, an exercise was performed to verify the existence and carrying values of assets recorded within the fixed asset register and to align the accounting treatment of fixed assets with EAG group accounting policies and applicable financial reporting standards.

 

As a result of this review, the directors determined that the basis and rationale supporting the historic revaluation reserve could not be substantiated and, accordingly, the reserve was released during the period. In addition, an impairment review was undertaken in respect of the Company’s fixed assets to ensure that the carrying values reflected the net book value of the assets existing and available for use at the balance sheet date.

 

The resulting adjustments have been recognised within these financial statements where the directors considered them necessary to present a true and fair view of the Company’s financial position as at 31 December 2025.

5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
6,941
80,825
Other debtors
131,326
532,423
138,267
613,248
AGROGEN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE 15 MONTH PERIOD ENDED 31 DECEMBER 2025
- 8 -
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
3,007,609
2,470,414
Trade creditors
54,885
72,398
Taxation and social security
-
0
10,916
Other creditors
234,007
170,366
3,296,501
2,724,094
7
Events after the reporting date

On 20 January 2026, subsequent to the reporting date, the Company was acquired by EAG No.2 Limited and became part of the EAG Bioenergy group.

 

At the date of acquisition, the Company had negative reserves. However, EAG identified potential for future growth and value creation following an operational restructuring programme and, accordingly, proceeded with the acquisition as part of its wider strategic objectives.

 

Following the acquisition, the newly appointed directors assumed responsibility for the preparation of the financial statements for the period ended 31 December 2025, being a period prior to their ownership and control of the Company. As part of the post-acquisition integration process, the directors undertook a review to align the Company’s accounting policies and procedures with those of the EAG group and to ensure compliance with applicable financial reporting standards.

 

This review included an assessment of the Company’s fixed asset records and related accounting treatments. Any adjustments arising from this review that were identified as relating to conditions existing at the reporting date have been reflected within these financial statements where appropriate. The acquisition itself is considered a non-adjusting post balance sheet event.

2025-12-312024-10-01falsefalsefalse25 September 2026CCH SoftwareCCH Accounts Production 2026.100No description of principal activityMr C KerrMr W O'MalleyMr R A Greenow084841292024-10-012025-12-31084841292025-12-31084841292024-09-3008484129core:LandBuildings2025-12-3108484129core:OtherPropertyPlantEquipment2025-12-3108484129core:LandBuildings2024-09-3008484129core:OtherPropertyPlantEquipment2024-09-3008484129core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3108484129core:CurrentFinancialInstrumentscore:WithinOneYear2024-09-3008484129core:WithinOneYear2025-12-3108484129core:WithinOneYear2024-09-3008484129core:CurrentFinancialInstruments2025-12-3108484129core:CurrentFinancialInstruments2024-09-3008484129core:ShareCapital2025-12-3108484129core:ShareCapital2024-09-3008484129core:RevaluationReserve2025-12-3108484129core:RevaluationReserve2024-09-3008484129core:RetainedEarningsAccumulatedLosses2025-12-3108484129core:RetainedEarningsAccumulatedLosses2024-09-3008484129core:ShareCapital2023-09-3008484129core:RevaluationReserve2023-09-3008484129core:RetainedEarningsAccumulatedLosses2023-09-3008484129bus:Director22024-10-012025-12-3108484129core:RetainedEarningsAccumulatedLosses2023-10-012024-09-30084841292023-10-012024-09-3008484129core:RetainedEarningsAccumulatedLosses2024-10-012025-12-3108484129core:RevaluationReserve2023-10-012024-09-3008484129core:RevaluationReserve2024-10-012025-12-3108484129core:LandBuildingscore:LongLeaseholdAssets2024-10-012025-12-3108484129core:PlantMachinery2024-10-012025-12-3108484129core:FurnitureFittings2024-10-012025-12-3108484129core:LandBuildings2024-09-3008484129core:OtherPropertyPlantEquipment2024-09-30084841292024-09-3008484129core:LandBuildings2024-10-012025-12-3108484129core:OtherPropertyPlantEquipment2024-10-012025-12-3108484129bus:PrivateLimitedCompanyLtd2024-10-012025-12-3108484129bus:SmallCompaniesRegimeForAccounts2024-10-012025-12-3108484129bus:FRS1022024-10-012025-12-3108484129bus:AuditExemptWithAccountantsReport2024-10-012025-12-3108484129bus:Director12024-10-012025-12-3108484129bus:Director32024-10-012025-12-3108484129bus:FullAccounts2024-10-012025-12-31xbrli:purexbrli:sharesiso4217:GBP